• LAST PRICE
    12.9800
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    0.0000 / 12.9800
  • Day Range
    ---
  • 52 Week Range
    Low 5.8200
    High 81.1900
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 12.79
TimeVolumeALXO
09:32 ET397813.12
09:34 ET100013.01
09:36 ET163012.95
09:38 ET10012.875
09:39 ET23513.0014
09:43 ET40013.02
09:45 ET36513
09:50 ET10013.03
09:52 ET13013.0607
09:59 ET50013.215
10:01 ET80013.22
10:03 ET23713.13
10:06 ET10013.18
10:08 ET120013.16
10:10 ET122513.135
10:12 ET12413.17
10:14 ET30013.25
10:15 ET80013.37
10:17 ET20013.3254
10:19 ET10013.47
10:24 ET10013.47
10:26 ET110013.42
10:28 ET10013.52
10:30 ET96013.52
10:32 ET10013.52
10:33 ET30013.45
10:35 ET100013.48
10:37 ET142513.45
10:39 ET60013.37
10:42 ET80013.47
10:44 ET20013.47
10:46 ET150013.475
10:48 ET63813.36
10:50 ET20013.39
10:51 ET40013.43
10:53 ET20013.41
10:55 ET10013.46
10:57 ET30013.4
11:00 ET10013.47
11:04 ET40013.39
11:08 ET210013.23
11:09 ET28313.2
11:11 ET20013.12
11:13 ET10013.08
11:15 ET40013.085
11:18 ET35013.085
11:20 ET44413.01
11:22 ET89213.06
11:24 ET30013.07
11:26 ET40013
11:27 ET40013.035
11:31 ET34512.955
11:33 ET30012.97
11:36 ET10012.98
11:38 ET40012.91
11:40 ET20012.915
11:42 ET20012.91
11:44 ET10012.88
11:45 ET20012.85
11:47 ET75012.85
11:49 ET218212.81
11:51 ET20012.765
11:54 ET70012.86
11:56 ET20012.78
11:58 ET60012.77
12:00 ET40012.795
12:02 ET20012.77
12:03 ET20012.83
12:05 ET20012.84
12:07 ET10012.8628
12:16 ET140012.76
12:18 ET50312.83
12:21 ET45012.87
12:23 ET60012.89
12:25 ET10012.9
12:34 ET30012.95
12:36 ET20012.97
12:38 ET211713.05
12:41 ET47612.995
12:45 ET35012.95
12:48 ET20012.96
12:50 ET10012.96
12:52 ET60012.97
12:54 ET50012.9604
12:57 ET20013.02
12:59 ET305612.92
01:01 ET39412.94
01:06 ET30012.9
01:10 ET139512.86
01:12 ET10012.86
01:15 ET10012.865
01:17 ET10012.84
01:19 ET130012.92
01:28 ET40012.88
01:32 ET30012.88
01:33 ET56112.88
01:35 ET85212.86
01:37 ET20012.88
01:42 ET40012.86
01:44 ET20012.88
01:48 ET20012.85
01:50 ET20012.83
01:51 ET10012.825
01:53 ET10012.83
01:55 ET20012.81
02:00 ET20012.77
02:02 ET70012.78
02:04 ET40012.79
02:08 ET77512.76
02:09 ET10012.78
02:15 ET60512.78
02:22 ET10012.81
02:24 ET22512.81
02:27 ET314712.85
02:29 ET10012.86
02:31 ET60012.82
02:33 ET59912.81
02:36 ET10012.84
02:42 ET10012.79
02:44 ET10012.76
02:45 ET30012.79
02:49 ET30012.745
02:51 ET40012.755
02:54 ET30012.72
02:56 ET10012.73
03:00 ET20012.75
03:02 ET10512.79
03:03 ET10012.79
03:05 ET40012.77
03:09 ET40012.755
03:18 ET40012.77
03:20 ET10012.755
03:21 ET30012.75
03:25 ET55012.77
03:27 ET10012.77
03:30 ET10012.805
03:32 ET80012.82
03:34 ET20012.82
03:36 ET10012.84
03:39 ET100012.825
03:41 ET10012.815
03:43 ET20012.82
03:45 ET210012.86
03:48 ET40012.84
03:50 ET50612.88
03:52 ET150012.92
03:54 ET50012.92
03:56 ET170012.96
03:57 ET406313.01
03:59 ET1931912.98
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesALXO
ALX Oncology Holdings Inc
521.2M
-4.8x
---
United StatesAKRO
Akero Therapeutics Inc
516.2M
-4.0x
---
United StatesVERA
Vera Therapeutics Inc
529.9M
-9.6x
---
United StatesINO
Inovio Pharmaceuticals Inc
595.5M
-1.6x
---
United StatesCNTA
Centessa Pharmaceuticals PLC
446.7M
-1.7x
---
United StatesEWTX
Edgewise Therapeutics Inc
519.4M
-8.7x
---
As of 2022-08-12

Company Information

ALX Oncology Holdings Inc. is a clinical-stage immuno-oncology company. The Company is focused on helping patients fight cancer by developing a pipeline of product candidates based on protein engineering and oncology led by the cluster of differentiation 47 (CD47) blocker. It is developing a checkpoint inhibitor designed to have an affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches. Its lead product candidate, evorpacept, is a CD47 blocking biologic in development as a combination therapy with other anti-cancer agents for treatment of various oncology indications, including myelodysplastic syndromes (MDS), acute myeloid leukemia (AML), head and neck squamous cell carcinomas (HNSCC), gastric and breast cancer. Its preclinical program is focused on developing ALTA-002, which combines its signal regulatory protein alpha (SIRPa) and toll-like receptor 9 agonist antibody conjugate (TRAAC).

Contact Information

Headquarters
323 Allerton AvenueSOUTH SAN FRANCISCO, CA, United States 94080
Phone
650-466-7125
Fax
302-655-5049

Executives

Executive Chairman of the Board
Corey Goodman
President, Chief Executive Officer, Director
Jaume Pons
Chief Financial Officer, Principal Accounting Officer
Peter Garcia
Chief Accounting Officer, Vice President - Finance
Shelly Pinto
Chief Medical Officer, Director
Sophia Randolph

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$521.2M
Revenue (TTM)
$0.00
Shares Outstanding
40.7M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-2.72
Book Value
$8.94
P/E Ratio
-4.8x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.